Name: Nonsense Mutation Correction in Human Diseases: An Approach for Targeted Medicine (en Inglés)
Price: 287.91 PEN
Availability: InStock
Author: Fabrice Lejeune; Hana Benhabiles; Jieshuang Jia
ISBN: 9780128044681

portada Nonsense Mutation Correction in Human Diseases: An Approach for Targeted Medicine (en Inglés)

Formato

Libro Físico

Editorial

Academic Press

Autor

Fabrice Lejeune; Hana Benhabiles; Jieshuang Jia

Año

2016

Idioma

Inglés

N° páginas

190

Encuadernación

Tapa Blanda

ISBN13

9780128044681

N° edición

Categorías

Bioquímica

Nonsense Mutation Correction in Human Diseases: An Approach for Targeted Medicine (en Inglés)

Fabrice Lejeune; Hana Benhabiles; Jieshuang Jia (Autor) · Academic Press · Tapa Blanda

Libro Físico

S/ 287,91

S/ 575,82

Ahorras: S/ 287,91

50% descuento

Envío normal

Origen: Reino Unido (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Martes 04 de Junio y el Miércoles 19 de Junio.

Lo recibirás en cualquier lugar de Perú entre 2 y 5 días hábiles luego del envío.

Reseña del libro "Nonsense Mutation Correction in Human Diseases: An Approach for Targeted Medicine (en Inglés)"

Nonsense Mutation Correction in Human Diseases: An Approach for Targeted Medicine provides an introduction on genetic diseases, discusses the prevalence of nonsense mutations, the consequences of a nonsense mutation for the expression of the mutant gene, and the presentation of the nonsense-mediated mRNA decay (NMD). It presents the mechanism of action and rationale associated with each strategy to correct nonsense mutations with the results of clinical trials to further support this basis. In addition, the book shows how it may be possible to combine several of these strategies to ultimately improve the efficiency of correction, also suggesting the future goals and objectives to improve treatment modalities in this evolving sphere of personalized medicine. Features basic biological and clinical constructs that inform the application of genomic data to clinical decision-makingIncludes theories and methods that can be used to link bio-molecular and clinical phenotypes so as to enable integrative hypothesis discovery, testing, and downstream evidence-based practiceProvides design patterns and use cases that contextualize the clinical decision-making and evidence-based practice relative to real world requirements and stakeholders